European heart journal · 2025
Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
Consensus StatementСтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Imazio Massimo, Basso Cristina, Brucato Antonio, Klingel Karin, Kuchynka Petr, Lazaros George, Merlo Marco, Sinagra Gianfranco, Adler Yehuda, Bucciarelli Ducci Chiara, Cameli Matteo, Castelletti Silvia, Caforio Alida Linda, Crotti Lia, Dagna Lorenzo, Frustaci Andrea, Klein Allan, Kuusisto Johanna, Lopez Sainz Angela, Marcolongo Renzo, Pantazis Antonis, Rigopoulos Angelos G, Ristic Arsen, Seferovic Petar, Sheppard Mary, Tschöpe Carsten, Lüscher Thomas
Аннотация
The aim of the present clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases is to review the current knowledge on the epidemiology, pathogenesis, diagnosis, therapy, and outcomes of myocardial and pericardial complications of coronavirus disease 2019 (COVID-19) and vaccination in order to improve the awareness and clinical confidence on the management of patients with these complications. The risk of myopericardial complications is especially higher within 1 month of COVID-19 disease and vaccination. Forms related to the disease are generally more common and severe than those related to vaccination. Even if vaccination against COVID-19 increases myocarditis risk, this risk is lower in vaccinated than non-vaccinated COVID-19 individuals, supporting the vaccine use. Overall, COVID-19 related complications, especially myocarditis, are relatively rare.